Medicare Enrolled

Dr. Joseph Albanese, DO

Nephrology · Brick, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1541 ROUTE 88 STE A, Brick, NJ 08724
7328363200
In practice since 2006 (19 years)
NPI: 1306850599 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Albanese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Albanese? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Albanese

Dr. Joseph Albanese is a nephrology specialist in Brick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Albanese performed 2,664 Medicare services across 1,387 unique beneficiaries.

Between the years covered by Open Payments, Dr. Albanese received a total of $23,864 from 47 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Albanese is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 23% volume in NJ $23,864 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,664
Medicare services
Top 23% in NJ for nephrology
1,387
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,083 $77 $175
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
992 $65 $115
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
216 $140 $325
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
137 $99 $170
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
91 $91 $235
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
70 $130 $270
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
47 $294 $455
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
14 $245 $385
New patient office visit, complex (60-74 min) 14 $159 $335
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,864
Total received (2018-2024)
Avg $3,409/year across 7 years
Top 3% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,008 (71.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,857 (28.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,548
2023
$1,389
2022
$1,400
2021
$895
2020
$243
2019
$784
2018
$605

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$15,918
Lilly USA, LLC
$951
Amgen Inc.
$215
AstraZeneca Pharmaceuticals LP
$191
Novo Nordisk Inc
$181
Ardelyx, Inc.
$179
Medtronic, Inc.
$152
Otsuka America Pharmaceutical, Inc.
$119
Travere Therapeutics, Inc.
$106
Outset Medical Inc
$101
AKEBIA THERAPEUTICS INC
$63
Aurinia Pharma U.S., Inc.
$55
Fresenius USA Marketing, Inc.
$48
Bayer Healthcare Pharmaceuticals Inc.
$39
Novartis Pharmaceuticals Corporation
$33
CALLIDITAS THERAPEUTICS US INC.
$32
Daiichi Sankyo Inc.
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$17
CorMedix Inc.
$17
GlaxoSmithKline, LLC.
$16
OPKO Pharmaceuticals, LLC
$16
ANI Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$15
Vifor Pharma, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
Mallinckrodt Hospital Products Inc.
$13
Top 3 companies account for 92.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$16,009
Lilly USA, LLC
$1,083
AstraZeneca Pharmaceuticals LP
$979
Novo Nordisk Inc
$419
Esperion Therapeutics, Inc.
$412
Otsuka America Pharmaceutical, Inc.
$406
Bard Peripheral Vascular, Inc.
$400
Amgen Inc.
$342
Janssen Pharmaceuticals, Inc
$274
Medtronic, Inc.
$247
Vifor Pharma, Inc.
$208
Takeda Pharmaceuticals U.S.A., Inc.
$196
Ardelyx, Inc.
$179
Aurinia Pharma U.S., Inc.
$179
AKEBIA THERAPEUTICS INC
$168
GlaxoSmithKline, LLC.
$157
Biohaven Pharmaceuticals, Inc.
$150
Fresenius USA Marketing, Inc.
$146
Travere Therapeutics, Inc.
$146
Bayer Healthcare Pharmaceuticals Inc.
$141
OPKO Pharmaceuticals, LLC
$138
Otsuka Pharmaceutical Development & Commercialization, Inc.
$125
Daiichi Sankyo Inc.
$123
Genentech USA, Inc.
$122
Relypsa, Inc.
$113
Horizon Therapeutics plc
$112
Outset Medical Inc
$101
E.R. Squibb & Sons, L.L.C.
$96
Kerecis Limited
$91
Novartis Pharmaceuticals Corporation
$80
PORTOLA PHARMACEUTICALS, INC.
$80
Amarin Pharma Inc.
$70
Alnylam Pharmaceuticals Inc.
$66
Mallinckrodt Hospital Products Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$37
CALLIDITAS THERAPEUTICS US INC.
$32
ARBOR PHARMACEUTICALS, INC.
$28
Mallinckrodt Enterprises LLC
$27
Keryx Biopharmaceuticals, Inc.
$23
CorMedix Inc.
$17
Exeltis, USA Inc.
$16
Merck Sharp & Dohme LLC
$16
ANI Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$15
Corcept Therapeutics
$14
Horizon Pharma plc
$12
BAXTER HEALTHCARE
$11
Top 3 companies account for 75.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANDEXXA · AURYXIA · Aranesp · Auryxia · BENLYSTA · BEVYXXA · COVERA · Crysvita · DIFICID · DefenCath · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · ENDURANT IIS · ENTRESTO · Edarbyclor · FARXIGA · GATTEX · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerecis Omega3 SurgiClose · Kerendia · Korlym · Korsuva · LOKELMA · LUPKYNIS · MOUNJARO · NEXLETOL · NEXLIZET · NURTEC ODT · OXLUMO · Ozempic · PURIFIED CORTROPHIN GEL · Phoslyra · RAYALDEE · RYBELSUS · Rayaldee · Rayaldee 30 · Renal - Sharesource · Rituxan · Rivfloza · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Uloric · Vafseo · Vascepa · Velphoro · Veltassa · Wegovy · XARELTO · XPHOZAH 30 MG · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for nephrology in NJ.

Looking for a nephrology specialist in Brick?
Compare nephrologists in the Brick area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
55
Per 100K population
8.5
County median income
$86,411
Nearest hospital
OCEAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Albanese is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NJ), with speaking/promotional industry engagement in the top 3% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Albanese experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Albanese performed 1,083 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Albanese receive payments from pharmaceutical companies?
Yes. Dr. Albanese received a total of $23,864 from 47 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Albanese's costs compare to other nephrologists in Brick?
Dr. Albanese's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Albanese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →